Session information
- Title:
- Introduction to Immune effector cell therapy
- Description:
-
This session provides an overview of immune effector cell (IEC) therapies including types of licensed and unlicensed products and their clinical indications. This session also covers the main considerations along the complete IEC therapy pathway from procurement of starting materials to clinical delivery, governance and institutional readiness.
- Hierarchy:
- Advanced Therapy Medicinal Products (ATMP) > Advanced Therapy Medicinal Products > Introduction to Immune effector cell therapy
- Created:
- 8 Jul 2021
- Last Major Update:
- 8 Jul 2021
- Keywords:
- 830-0005, Advanced, Medicinal, Products, ATMP, immune effector cell, Gene therapy, CAR T, HLA, MHC, AAV, GMO
- Quicklink:
- 830-0005
Share this item
- Copy URL
Overall rating
4.5/5
4.5/5
Content
4.5/5
4.5/5
Presentation
4.5/5
4.5/5
Interactivity
4.5/5
4.5/5
Self assessments
4.6/5
4.6/5
Overall rating
4.5/5
4.5/5
Content
4.5/5
4.5/5
Presentation
4.5/5
4.5/5
Interactivity
4.5/5
4.5/5
Self assessments
4.6/5
4.6/5
- Title:
- Introduction to Immune effector cell therapy
- Description:
-
This session provides an overview of immune effector cell (IEC) therapies including types of licensed and unlicensed products and their clinical indications. This session also covers the main considerations along the complete IEC therapy pathway from procurement of starting materials to clinical delivery, governance and institutional readiness.
- Hierarchy:
- Advanced Therapy Medicinal Products (ATMP) > Advanced Therapy Medicinal Products > Introduction to Immune effector cell therapy
- Created:
- 8 Jul 2021
- Last Major Update:
- 8 Jul 2021
- Keywords:
- 830-0005, Advanced, Medicinal, Products, ATMP, immune effector cell, Gene therapy, CAR T, HLA, MHC, AAV, GMO
- Quicklink:
- 830-0005